Ribonuclease P-mediated Inhibition of Human Cytomegalovirus Gene Expression and Replication Induced by Engineered External Guide Sequences

Overview

Journal RNA Biol

Specialty Molecular Biology

Date 2012 Sep 29

PMID 23018778

Citations 8

Authors

Xiaohong Jiang

Yuan-Chuan Chen

Hao Gong

Phong Trang

Sangwei Lu

Fenyong Liu

Affiliations

Soon will be listed here.

Abstract

External guide sequences (EGSs) are RNA molecules that can bind to a target mRNA and direct ribonuclease P (RNase P), a tRNA processing enzyme, for specific cleavage of the target mRNA. Using an in vitro selection procedure, we have previously generated EGS variants that efficiently direct human RNase P to cleave a target mRNA in vitro. In this study, we constructed EGSs from a variant to target the overlapping region of the mRNAs coding for human cytomegalovirus (HCMV) capsid scaffolding protein (CSP) and assemblin, which are essential for viral capsid formation. The EGS variant was about 40-fold more active in directing human RNase P to cleave the mRNA in vitro than the EGS derived from a natural tRNA. Moreover, a reduction of about 98% and 75% in CSP/assemblin gene expression and a reduction of 7000- and 250-fold in viral growth were observed in HCMV-infected cells that expressed the variant and the tRNA-derived EGS, respectively. Our study shows that the EGS variant is more effective in blocking HCMV gene expression and growth than the tRNA-derived EGS. Moreover, these results demonstrate the utility of highly active EGS RNA variants in gene targeting applications including anti-HCMV therapy.

Citing Articles

Mapping of RNase P Ribozyme Regions in Proximity with a Human RNase P Subunit Protein Using Fe(II)-EDTA Cleavage and Nuclease Footprint Analyses.

Trang P, Smith A, Liu F Methods Mol Biol. 2023; 2666:55-67.

PMID: 37166656 DOI: 10.1007/978-1-0716-3191-1_4.

Inhibition of human cytomegalovirus major capsid protein expression and replication by ribonuclease P-associated external guide sequences.

Deng Q, Liu Y, Li X, Yan B, Sun X, Tang W RNA. 2019; 25(5):645-655.

PMID: 30803999 PMC: 6467005. DOI: 10.1261/rna.069682.118.

Engineered RNase P Ribozymes Effectively Inhibit the Infection of Murine Cytomegalovirus in Animals.

Li W, Liu Y, Wang Y, Li R, Trang P, Tang W Theranostics. 2018; 8(20):5634-5644.

PMID: 30555569 PMC: 6276291. DOI: 10.7150/thno.27776.

Viral tRNA Mimicry from a Biocommunicative Perspective.

Ariza-Mateos A, Gomez J Front Microbiol. 2017; 8:2395.

PMID: 29259593 PMC: 5723415. DOI: 10.3389/fmicb.2017.02395.

RNase P-Mediated Sequence-Specific Cleavage of RNA by Engineered External Guide Sequences.

Derksen M, Mertens V, Pruijn G Biomolecules. 2015; 5(4):3029-50.

PMID: 26569326 PMC: 4693268. DOI: 10.3390/biom5043029.

References

Trang P, Lee M, Nepomuceno E, Kim J, Zhu H, Liu F . Effective inhibition of human cytomegalovirus gene expression and replication by a ribozyme derived from the catalytic RNA subunit of RNase P from Escherichia coli. Proc Natl Acad Sci U S A. 2000; 97(11):5812-7. PMC: 18516. DOI: 10.1073/pnas.100101797. View

Szostak J . In vitro genetics. Trends Biochem Sci. 1992; 17(3):89-93. DOI: 10.1016/0968-0004(92)90242-2. View

Dunn W, Chou C, Li H, Hai R, Patterson D, Stolc V . Functional profiling of a human cytomegalovirus genome. Proc Natl Acad Sci U S A. 2003; 100(24):14223-8. PMC: 283573. DOI: 10.1073/pnas.2334032100. View

Forster A, Altman S . External guide sequences for an RNA enzyme. Science. 1990; 249(4970):783-6. DOI: 10.1126/science.1697102. View

Juhling F, Morl M, Hartmann R, Sprinzl M, Stadler P, Putz J . tRNAdb 2009: compilation of tRNA sequences and tRNA genes. Nucleic Acids Res. 2008; 37(Database issue):D159-62. PMC: 2686557. DOI: 10.1093/nar/gkn772. View

Hurlburt W, Weinheimer S, Newcomb W, Brown J, Gao M . Phenotype of the herpes simplex virus type 1 protease substrate ICP35 mutant virus. J Virol. 1994; 68(9):5384-94. PMC: 236938. DOI: 10.1128/JVI.68.9.5384-5394.1994. View

Hnatyszyn H, Spruill G, Young A, Seivright R, Kraus G . Long-term RNase P-mediated inhibition of HIV-1 replication and pathogenesis. Gene Ther. 2002; 8(24):1863-71. DOI: 10.1038/sj.gt.3301606. View

Pyle A, McSwiggen J, Cech T . Direct measurement of oligonucleotide substrate binding to wild-type and mutant ribozymes from Tetrahymena. Proc Natl Acad Sci U S A. 1990; 87(21):8187-91. PMC: 54920. DOI: 10.1073/pnas.87.21.8187. View

Baldanti F, Underwood M, Talarico C, Simoncini L, Sarasini A, Biron K . The Cys607-->Tyr change in the UL97 phosphotransferase confers ganciclovir resistance to two human cytomegalovirus strains recovered from two immunocompromised patients. Antimicrob Agents Chemother. 1998; 42(2):444-6. PMC: 105432. DOI: 10.1128/AAC.42.2.444. View

10.

Li Y, Altman S . Artificial regulation of gene expression in Escherichia coli by RNase P. Proc Natl Acad Sci U S A. 1995; 92(24):11115-9. PMC: 40582. DOI: 10.1073/pnas.92.24.11115. View

11.

Bertrand E, Castanotto D, Zhou C, Carbonnelle C, Lee N, Good P . The expression cassette determines the functional activity of ribozymes in mammalian cells by controlling their intracellular localization. RNA. 1997; 3(1):75-88. PMC: 1369464. View

12.

Evans D, Marquez S, Pace N . RNase P: interface of the RNA and protein worlds. Trends Biochem Sci. 2006; 31(6):333-41. DOI: 10.1016/j.tibs.2006.04.007. View

13.

Zhu J, Trang P, Kim K, Zhou T, Deng H, Liu F . Effective inhibition of Rta expression and lytic replication of Kaposi's sarcoma-associated herpesvirus by human RNase P. Proc Natl Acad Sci U S A. 2004; 101(24):9073-8. PMC: 428475. DOI: 10.1073/pnas.0403164101. View

14.

Liu F, Altman S . Differential evolution of substrates for an RNA enzyme in the presence and absence of its protein cofactor. Cell. 1994; 77(7):1093-100. DOI: 10.1016/0092-8674(94)90448-0. View

15.

Kawa D, Wang J, Yuan Y, Liu F . Inhibition of viral gene expression by human ribonuclease P. RNA. 1998; 4(11):1397-406. PMC: 1369712. DOI: 10.1017/s1355838298980918. View

16.

Ma M, Benimetskaya L, Lebedeva I, Dignam J, Takle G, Stein C . Intracellular mRNA cleavage induced through activation of RNase P by nuclease-resistant external guide sequences. Nat Biotechnol. 2000; 18(1):58-61. DOI: 10.1038/71924. View

17.

Yu D, Silva M, Shenk T . Functional map of human cytomegalovirus AD169 defined by global mutational analysis. Proc Natl Acad Sci U S A. 2003; 100(21):12396-401. PMC: 218769. DOI: 10.1073/pnas.1635160100. View

18.

Drew W . Cytomegalovirus infection in patients with AIDS. Clin Infect Dis. 1992; 14(2):608-15. DOI: 10.1093/clinids/14.2.608-a. View

19.

Marvin M, Engelke D . Broadening the mission of an RNA enzyme. J Cell Biochem. 2009; 108(6):1244-51. PMC: 2800852. DOI: 10.1002/jcb.22367. View

20.

Welch A, Woods A, McNally L, Cotter R, Gibson W . A herpesvirus maturational proteinase, assemblin: identification of its gene, putative active site domain, and cleavage site. Proc Natl Acad Sci U S A. 1991; 88(23):10792-6. PMC: 53017. DOI: 10.1073/pnas.88.23.10792. View